Australija - anglų - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - ascorbic acid,biotin,calcium carbonate,calcium pantothenate,colecalciferol,cyanocobalamin,d-alpha-tocopheryl acid succinate,ferrous fumarate,heavy magnesium oxide,nicotinamide,potassium iodide,pyridoxine hydrochloride,riboflavin,selenomethionine,thiamine hydrochloride,zinc gluconate -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - ascorbic acid,betacarotene,calcium hydrogen phosphate dihydrate,calcium pantothenate,cyanocobalamin,d-alpha-tocopheryl acid succinate,ferrous fumarate,folic acid,fish oil - rich in omega-3 acids,fucus vesiculosus,heavy magnesium oxide,nicotinamide,potassium iodide,pyridoxine hydrochloride,riboflavin,thiamine hydrochloride,zinc gluconate,zingiber officinale -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - folic acid, quantity: 0.4 mg; potassium iodide, quantity: 0.1 mg (equivalent: potassium, qty 23.6 microgram; equivalent: iodine, qty 76.4 microgram); cyanocobalamin, quantity: 1.5 microgram; zingiber officinale, quantity: 50 mg (equivalent: zingiber officinale, qty 500 mg); fucus vesiculosus, quantity: 60 mg (equivalent: fucus vesiculosus, qty 300 mg; equivalent: iodine, qty 0.03 mg); thiamine hydrochloride, quantity: 1.27 mg (equivalent: thiamine, qty 1 mg); riboflavin, quantity: 1 mg; calcium pantothenate, quantity: 5.44 mg (equivalent: pantothenic acid, qty 5 mg; equivalent: calcium, qty 0.458 mg); nicotinamide, quantity: 10 mg; pyridoxine hydrochloride, quantity: 1.22 mg (equivalent: pyridoxine, qty 1 mg); betacarotene, quantity: 1.5 mg; d-alpha-tocopherol, quantity: 10.07 mg; zinc gluconate, quantity: 69.67 mg (equivalent: zinc, qty 10 mg); ferrous fumarate, quantity: 60.85 mg (equivalent: iron, qty 20 mg); heavy magnesium oxide, quantity: 50 mg (equivalent: magnesium, qty 30.15 mg); ascorbic acid, quantity: 50 mg; calcium hydrogen phosphate, quantity: 169.74 mg (equivalent: calcium, qty 50 mg) - capsule, soft - excipient ingredients: soya oil; hydrogenated vegetable oil; yellow beeswax; lecithin; gelatin; glycerol; titanium dioxide; amaranth; brilliant blue fcf; sunset yellow fcf; purified water; maltodextrin - maintain/support healthy pregnancy

Australija - anglų - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - biotin, quantity: 100 microgram; thiamine hydrochloride, quantity: 1.68 mg (equivalent: thiamine, qty 1.5 mg); riboflavin, quantity: 1.5 mg; nicotinamide, quantity: 20 mg; pyridoxine hydrochloride, quantity: 60.8 mg (equivalent: pyridoxine, qty 50 mg); cyanocobalamin, quantity: 50 microgram; ascorbic acid, quantity: 500 mg; colecalciferol, quantity: 10 microgram; d-alpha-tocopheryl acid succinate, quantity: 41.32 mg; zinc gluconate, quantity: 104.53 mg (equivalent: zinc, qty 15 mg); potassium iodide, quantity: 200 microgram (equivalent: iodine, qty 150 microgram; equivalent: potassium, qty 47.1 microgram); calcium pantothenate, quantity: 5.46 mg (equivalent: pantothenic acid, qty 5 mg); calcium carbonate, quantity: 500 mg (equivalent: calcium, qty 200 mg); selenomethionine, quantity: 200 microgram (equivalent: selenium, qty 80 microgram); heavy magnesium oxide, quantity: 331.67 mg (equivalent: magnesium, qty 200 mg); ubidecarenone, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate - maintain/support healthy pregnancy

Australija - anglų - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - esmolol hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide; sodium chloride; glacial acetic acid; sodium acetate trihydrate - supraventricular tachycardia,esmolol juno is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. esmolol juno is also indicated in non compensatory sinus tachycardia where, in the physician's judgement, the rapid heart rate requires specific intervention. esmolol juno is not intended for use in chronic settings where transfer to another agent is anticipated or for treatment periods greater than 24 hours duration.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - indicated for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - indicated for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.